No Data
No Data
Zhongtai Securities: Steady performance under the influence of policies and fundamentals, grasping investment opportunities driven by medical device innovation+ inflection points
The medical device industry continues to grow rapidly. It is optimistic about importation substitution and global development driven by innovation. Volume procurement policies will continue to be implemented, medical anti-corruption is expected to ease, and sector valuations are expected to gradually recover.
Peijia Medical Limited (HKG:9996) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing
To the annoyance of some shareholders, Peijia Medical Limited (HKG:9996) shares are down a considerable 28% in the last month, which continues a horrid run for the company. For any long-term shareh
Peijia Healthcare (09996.HK) was suspended due to financial asset evaluation, business operations were normal, and unaudited performance was improving
On April 2, Peijia Healthcare (09996.HK) issued an announcement stating that since the company is discussing the valuation of financial assets with the auditor (initial investment cost is HK$80 million) and is still awaiting certain information and supporting documents, the company will delay issuing the annual results announcement and suspend stock trading from April 2, pending publication of the audited annual results. It is worth noting that the 2023 annual results release deadline set by the Hong Kong Stock Exchange last Thursday has passed. Pegasus Healthcare is only one of many companies, such as Country Garden, Novartis Health, Hongjiu Fruit, and Yida China, which failed to release the audited results announcements in a timely manner. Moreover, it is only because
The results for the full year of 2023 were announced. What was the performance of innovative medical device companies under the collection test?
Hengqiang, the strongest in innovative medical devices
Peijia Medical-B (09996.HK) suspended trading this morning
On April 2, Gelonghui Medical-B (09996.HK) announced that trading of the company's shares will be suspended from 9:00 a.m. today (2/4/2024).
Peijia Medical-B (09996) suspended trading on April 2, pending publication of 2023 annual results
According to the Zhitong Finance App, Peijia Medical-B (09996) announced that trading of the company's shares will be suspended on the Hong Kong Stock Exchange Limited from 9:00 a.m. on April 2, 2024, pending publication of the 2023 annual results.
No Data